There is a paucity of information regarding the mechanisms through which ARID1A loss-of-function acts in cancer cells and there are conflicting reports regarding the effects of its inactivation: in ovarian cancer, a moderate knockdown was associated with increased proliferation [52]. This evidence concerns the gene ARID1A and ovarian carcinoma.